American Society of Gene & Cell Therapy (ASGCT) 17th Annual Meeting

美国基因学会

• 批准号: 8720363
• 负责人: David W Russell
• 金额: $ 1万
• 依托单位: AMERICAN SOCIETY OF GENE & CELL THERAPY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-07-15 至 2015-07-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8720363
• 关键词: American; Award; Awareness; Cell Therapy; Cells; District of Columbia; Education; Ethical Issues; Ethicists; Fostering; Funding; Genes; Genetic; Grant; Human; Knowledge; Mission; Oral; Participant; Peer Review; Postdoctoral Fellow; Process; Request for Proposals; Research; Scientific Advances and Accomplishments; Scientist; Societies; Students; Technology; Thinking; Time; Training; Travel; United States National Institutes of Health; Work; abstracting; base; clinical application; doctoral student; gene therapy; human disease; insight; meetings; member; posters; pre-doctoral; programs; public health relevance; symposium

DESCRIPTION (provided by applicant): American Society of Gene & Cell Therapy (ASGCT) was founded in 1996. ASGCT's mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. Our Annual Meeting represents the major educational initiative of the Society. This R13 proposal requests support for travel grants for trainees. Approximately 1/4 of our members are scientists in training working to develop clinically applicable gene and cell-based technologies. Trainee participation in the Annual Meeting is fostered by a distinctive educational program, numerous trainee travel awards, and recognition of outstanding scientific accomplishments through peer-reviewed trainee Excellence in Research Awards. Over the past decade, the ASGCT has offered 620 travel grants and 68 Research Awards, with 180 travel grants made possible by R13 grant awards from the NIH during that same time. Educational opportunities for travel awardees include exceptional plenary speakers, state-of-the-art scientific symposia, and educational sessions that review current thinking on a variety of topics. In addition to leading scientists and clinicians, the program includes ethicists and representatives from the FDA, OBA, and NIH so young scientists may gain insight into the compliance and ethical issues related to human gene therapy and cell therapy. Trainees are active presenters in oral abstract and poster presentations and the top trainee abstracts are recognized at the Presidential Symposium. The size of the ASGCT meeting (approximately 1,600 participants) is ideally suited to expose young scientists to leaders in the field, yet provide opportunities for trainees to present their work at the premier meeting in the field of gene and cell therapy. NIH support for the ASGCT Annual Meeting will allow continued educational and professional advancement of trainees in the field of cell and gene therapy in addition to the unique opportunity to network with leaders in the field.

描述（由申请人提供）：美国基因与细胞治疗协会 (ASGCT) 成立于 1996 年。ASGCT 的使命是促进知识、意识和教育的发展，从而促进基因和细胞疗法的发现和临床应用，以缓解人类疾病。我们的年会代表了协会的主要教育举措。该 R13 提案要求为受训人员提供旅费补助。我们大约 1/4 的成员是正在接受培训的科学家，致力于开发临床适用的基因和细胞技术。独特的教育计划、众多的实习生旅行奖以及通过同行评审的实习生卓越研究奖对杰出科学成就的认可，促进了实习生参与年会。在过去的十年中，ASGCT 提供了 620 项旅行补助金和 68 项研究奖，其中 180 项旅行补助金是由 NIH 同期颁发的 R13 补助金提供的。旅行获奖者的教育机会包括杰出的全体演讲者、最先进的科学知识 研讨会和教育会议，回顾当前对各种主题的想法。除了领先的科学家和临床医生外，该计划还包括来自 FDA、OBA 和 NIH 的伦理学家和代表，因此年轻科学家可以深入了解与人类基因治疗和细胞治疗相关的合规性和伦理问题。学员是口头摘要和海报展示的活跃演讲者，顶级学员摘要将在主席研讨会上得到认可。 ASGCT 会议的规模（约 1,600 名与会者）非常适合让年轻科学家接触该领域的领导者，同时为学员提供在基因和细胞治疗领域的重要会议上展示其工作的机会。 NIH 对 ASGCT 年会的支持除了提供与该领域领导者建立联系的独特机会外，还将使细胞和基因治疗领域的学员能够继续接受教育并获得专业进步。